Category: New products
-
Trial Shows Plant-Based Drug Helps Reduce Vaping
First results of a clinical trial show a drug derived from plants to aid in smoking cessation helps cut the use of e-cigarettes among non-smokers of burning tobacco.
-
Biotech, Undersea Researchers Partner on Carbon Capture Bacteria
A microbiome biotechnology company and an undersea research group are studying microorganisms that thrive in and consume intense carbon dioxide.
-
Biotech, Dairy Company Collaborate on Plant-Based Cheese
A maker of consumer dairy products and biotechnology food start-up are partnering on plant-based cheeses they say are indistinguishable from today’s dairy cheese.
-
Cancer Cell Therapy Biotech Launches, Raises $10M
A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds.
-
Seaweed Biomaterials Start-Up Gains $5M in Early Funds
A new company creating biomaterials for agriculture and consumer products from large seaweed blooms is adding $5 million in its first venture funding round.
-
Trial Okayed for Glaucoma Treatment Implant
A developer of treatments for eye diseases says it received clearance from FDA to begin a clinical trial of a sustained-release implant therapy for glaucoma.
-
Investor Backing Nanotech Drug Discovery Advances
A life science venture investor is funding further development of a lower-cost molecular-level drug discovery process using nanoscale synthetic DNA strands.
-
Self-Applied Patch Shown Feasible for Vaccine Delivery
A clinical trial shows a microneedle patch device for vaccine delivery applied by participants to their own arms works as well in the skin as when administered by clinicians.
-
T-Cell Biotech Gains €17.5M in Grant, Equity Funds
A developer of engineered immune cells to treat cancer and immune deficiencies is raising €17.5 million ($US 19.1 million) in equity and grant funding from an EU agency.
-
Chewable Covid-19 Drug Reduces Viral Load, Symptoms
Clinical trial results show an experimental drug given as a chewable tablet reduces viral load and symptoms in people with mild to moderate Covid-19 disease.